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Abstract
Little evidence is available to document that mechanical ventilation is an antecedent of systemic
inflammation in preterm humans. We obtained blood on postnatal day 14 from 726 infants born
before the 28th week of gestation and measured the concentrations of 25 inflammation-related
proteins. We created multivariable models to assess the relationship between duration of
ventilation and protein concentrations in the top quartile. Compared to newborns ventilated for
fewer than 7 days (N=247), those ventilated for 14 days (N=330) were more likely to have
elevated blood concentrations of pro-inflammatory cytokines (IL-1β, TNF-α), chemokines (IL-8,
MCP-1), an adhesion molecule (ICAM-1), and a matrix metalloprotease (MMP-9), and less likely
to have elevated blood concentrations of two chemokines (RANTES, MIP-1β), a matrix
metalloproteinase (MMP-1), and a growth factor (VEGF). Newborns ventilated for 7-13 days
(N=149) had systemic inflammation that approximated the pattern of newborns ventilated for 14
days. These relationships were not confounded by chorioamnionitis or antenatal corticosteroid
exposure, and were not altered appreciably among infants with and without bacteremia. These
findings suggest that two weeks of ventilation are more likely than shorter durations of ventilation
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to be accompanied by high blood concentrations of pro-inflammatory proteins indicative of
systemic inflammation, and by low concentrations of proteins that might protect from
inflammation-mediated organ injury.
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1. INTRODUCTION
Postnatal systemic inflammation in the very preterm newborn is followed by increased risks
of lung [1], and brain disorders [2-4]. To minimize such undesirable consequences of
systemic inflammation, we consider it prudent to search for the antecedents of systemic
inflammation. To date, we have documented that bacteremia is followed/accompanied by
systemic inflammation [5]. We now consider another potential postnatal stimulus for
systemic inflammation, mechanical ventilation.
In adult animals, mechanical ventilation leads to systemic inflammation [6]. In adult
humans, mechanical ventilation is accompanied by a systemic inflammatory response,
which is modified by strategies that minimize ventilator-induced lung injury, suggesting a
cause and effect relationship between lung inflammation and systemic inflammation [7].
In late preterm and term infants, brief periods of ventilation are accompanied by systemic
inflammation [8]. The studies of very preterm newborns, which have also documented
systemic inflammation associated with ventilation, have been limited in the number of
subjects and the number of indicators of inflammation [9-13].
In order to explore the relationship between the duration of ventilation and systemic
inflammation during the first two weeks after birth, we studied 726 infants born before the
28th week of gestation for whom we had information about placenta histology, about
ventilation on each of the first 14 days, and about levels of the blood concentrations of 25
inflammation-related proteins on postnatal day 14.
2. METHODS
2.1. Sample Description
This study is a secondary analysis of data from the ELGAN Study [14]. The ELGAN Study
was designed to identify characteristics and exposures that increase the risk of neurologic
disorders in ELGANs delivered before 28 weeks gestation. The infants enrolled in this study
were born between April 2002 and August 2004. A full description of the methods of the
ELGAN Study is provided elsewhere [14], including the enrollment and consent processes
that were approved by the individual institutional review boards. Here we focus on those
most relevant to this report. Because of financial constraints, the ELGAN Study measured
proteins only on infants who had a developmental evaluation at 24 months adjusted age.
Measurements were made on blood specimens obtained on or close to postnatal days 1, 7,
and 14.
2.2. Placenta Morphology
Samples were collected from placentas for histologic examination, and were processed for
morphologic assessment as part of routine clinical care. Details describing the criteria for
each histologic lesion are presented elsewhere [15]. In our analyses, placenta inflammation
was defined as any of the following four lesions: a) chorionic plate inflammation of grade 3
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(neutrophils up to amnionic epithelium) and stage 3 (>20 neutrophils/20x), b) external
membrane inflammation of grade 3 (numerous large or confluent foci of neutrophils), c)
umbilical cord inflammation of grade 3 or higher (neutrophils in perivascular Wharton’s
jelly), and d) neutrophilic infiltration into fetal stem vessels in the chorionic plate.
2.3. Obstetric and Newborn Variables
Gestational age estimates were based on a hierarchy of available information, including in
declining order, dates of embryo retrieval or intrauterine insemination or fetal ultrasound
before the 14th week (62%), fetal ultrasound at 14 or more weeks (29%), last menstrual
period without fetal ultrasound (7%), and gestational age recorded in the log of the neonatal
intensive care unit (1%). Antenatal corticosteroids were considered complete if the mother
received 2 doses of betamethasone or 4 doses of dexamethasone over 48 hours and the last
dose was 24 hours before delivery, and were considered partial if ACS treatment was begun
but not completed. The birth weight Z-score was calculated using a standard data set [16].
Infants were classified as having a patent ductus arteriosus (PDA) if the diagnosis was
assigned by the clinician, on the basis of signs and symptoms or by echocardiography, at any
time during the first 2 postnatal weeks.
We classified infants by the number of cumulative days they received mechanical
ventilation (either high-frequency or conventional mechanical ventilation) during the first 14
postnatal days. We collected detailed, daily information during the first postnatal week
about respiratory support, but for the second week, we recorded the number of days
ventilated only. Thus, we limited our analyses to the measure of days of ventilation.
2.4. Blood Collection and Protein Measurement
Drops of blood were collected on filter paper (Schleicher & Schuell 903) on the first
postnatal day (range: 1-3 days), the 7th postnatal day (range: 5-8 days), and the 14th
postnatal day (range: 12-15 days). Details about elution of proteins from blood spots and
measurement of the proteins with an electrochemiluminescence system are provided
elsewhere [17].
The Laboratory of Genital Tract Biology of the Department of Obstetrics, Gynecology and
Reproductive Biology at Brigham and Women’s Hospital, Boston measured the following
25 proteins: IL-1β (interleukin-1beta), IL-6 (interleukin-6), IL-6R (interleukin-6 receptor),
TNF-α (tumor necrosis factor-alpha), TNF-R1 (tumor necrosis factor-alpha-receptor1),
TNF-R2 (tumor necrosis factor-alpha-receptor2), IL-8 (CXCL8) (interleukin-8), MCP-1
(CCL2) (monocyte chemotactic protein-1), MCP-4 (CCL13) (monocyte chemotactic
protein-4) (CCL13), MIP-1β (CCL4) (macrophage inflammatory protein-1β) (CCL4),
RANTES (CCL5) (regulated upon activation, normal T-cell expressed, and [presumably]
secreted), I-TAC ( CXCL11) (interferon-inducible T cell alpha-chemoattractant), ICAM-1
(CD54) (intercellular adhesion molecule-1), ICAM-3 (CD50) (intercellular adhesion
molecule-3), VCAM-1 (CD106) (vascular cell adhesion molecule-1), E-SEL (CD62E) (E-
selectin) (CD62E), MMP-1 (matrix metalloproteinase-1), MMP-9 (matrix
metalloproteinase-9), CRP (c-reactive protein), SAA (serum amyloid A), MPO
(myeloperoxidase), VEGF (vascular endothelial growth factor), VEGF-R1 (vascular
endothelial growth factor-receptor1), VEGF-R2 (vascular endothelial growth factor-
receptor2), and IGFBP-1 (insulin growth factor binding protein-1).
Measurements of each protein were normalized to mg total protein. A protein concentration
was classified in the top quartile in comparison to the concentrations of all other
concentrations of that protein on that day among all the other infants in the same gestational
age group.
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We evaluated the generalized null hypothesis that blood protein concentrations in the
highest quartile for gestational age (23-34, 25-26, and 27 weeks) on day 14 are not
associated with the length of ventilation during the first 14 postnatal days. We first created
multivariable logistic regression models of the risk of a day-14 protein concentration in the
top quartile that compared infants ventilated for 7-13 days and infants ventilated for 14 days
to the referent group of infants who were ventilated for less than 7 days and adjusted for the
three most important potential confounders, gestational age, placental inflammation, and
antenatal corticosteroids. Because bacteremia might be in the causal chain, we did not adjust
for postnatal bacteremia. Rather, we repeated our multivariable analyses in the sub-sample
of newborns who did not have documented bacteremia during the first two postnatal weeks.
We calculated the 99% confidence intervals rather than the conventional 95% confidence
interval because we wanted to minimize both type 1 and type 2 errors in light of multiple
comparisons.
To inform our understanding about the temporal relationship between ventilation and
systemic inflammation, we evaluated the hypothesis that systemic inflammation precedes
prolonged ventilation by comparing the median (and the 25th and 75th centiles) of ICAM-1,
TNF-α, IL-8, and CRP on early blood collection days (postnatal Days 1, and 7) among
newborns classified by gestational age group and duration of ventilation.
3. RESULTS
3.1 Cohort Description (Figure 1 and Table 1)
The cohort for this study included 726 infants. Fully 95% of these newborns received
ventilation assistance at some time in the early part of their NICU stay and 8% were
ventilator dependent during the 36th post-menstrual week. During the first 14 postnatal
days, 34% were ventilated for less than 7 days, 21% were ventilated for 7-13 days, and 45%
were ventilated for 14 days. Longer duration of ventilation was more common among
infants with low gestational age, low birth weight, low birth weight Z-score, PDA, and
receipt of surfactant and postnatal steroid compared to infants without these features (Table
1).
3.2. Distribution of Protein Concentrations (Figure 2)
Although our emphasis is on the highest quartile of concentrations of each inflammation-
related protein, the entire distribution of some protein concentrations was shifted upward
with each week of ventilation during the first two postnatal weeks. These proteins included
TNF-α, IL-8, MCP-1 and ICAM-1. By contrast, the entire distributions of RANTES and
MMP-1 were shifted downward with each week of ventilation. The distributions of
concentrations of SAA and CRP follow neither of these patterns.
When analyses were within strata defined by gestational age and duration of ventilation,
infants ventilated 14 days did not tend to have higher protein concentrations on postnatal
days 1 and 7 than their peers not ventilated on day 14 (data not shown).
3.3. Relationship between Duration of Mechanical Ventilation and Protein Concentrations
(Table 2)
After adjustment for gestational age, placental inflammation, and antenatal corticosteroids,
compared to infants who were ventilated for less than 7 days, infants who were ventilated
for 7-13 days during the first two postnatal weeks were more likely to have elevated
concentrations of CRP, SAA, TNF-α, IL-8, ICAM-1, and MMP-9 (data column 1), and less
likely to have an elevated concentration of RANTES. Infants ventilated every day during the
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first two weeks were more likely than those who were ventilated for less than 7 days to have
elevated concentrations of IL-1β, IL-6, TNF-α, TNF-R1, IL-8, MCP-1, ICAM-1, and
MMP-9 (data column 2) and less likely to have elevated concentrations of MIP-1β,
RANTES, I-TAC, MMP-1, and VEGF.
Similar multivariable models were also created for the sample of the 597 children who did
not have documented bacteremia during the first two postnatal weeks. This set of analyses
provided rather similar findings. For example, the elevated odds ratios for SAA, IL-8, and
ICAM-1, remained statistically significant for newborns who were ventilated 7-13 days
(data column 3). The point estimate of the odds ratio for MMP-9 remained the same, but the
99% confidence interval widened to include 1.0.
For the bacteremia-free newborns who were ventilated for 14 days, the odds ratios for IL-6,
TNF-α, TNF-R1, IL-8, MCP-1, ICAM-1, and MMP-9 remained statistically significantly
elevated, while the odds ratios for MIP-1β, RANTES, and MMP-1 remained statistically
significantly below 1.0. Point estimates of the odds ratios for IL-1β, I-TAC, and VEGF
remained the same as in the entire sample, but the confidence intervals were sufficiently
widened in this smaller sample that they were no longer statistically significant.
4. DISCUSSION
Among a large cohort of ELGANs, we found that the longer infants are ventilated during the
first 2 weeks following birth, the more likely they are to have elevated blood concentrations
of specific inflammation-related proteins, including pro-inflammatory cytokines,
chemokines, an adhesion molecule and a matrix metalloprotease, and decreased
concentrations of other proteins that have suspected protective and immunotrophic roles.
The pro-inflammatory response is similar to that observed in term and near term infants in
whom even brief periods of ventilation are associated with a systemic inflammatory
response [8]. Collectively, these observations suggest that systemic inflammation, which
might begin soon after the initiation of mechanical ventilation of preterm infants, escalates
during the first 2 postnatal weeks with continued exposure to ventilation.
4.1. possible explanations for what was found
Our finding that those ventilated the longest were most likely to have systemic inflammation
on postnatal day 14 can be interpreted in several ways. One explanation is that ventilation
causes lung inflammation, and selected inflammation-associated proteins then translocate
from the lung to the circulation. Under these circumstances, concentrations of these proteins
might increase with duration of ventilation. Circulating pro-inflammatory proteins might
then elicit a downstream response from other organs. For example, this might explain the
origin of proteins from the liver (e.g., SAA or CRP). Support for this possible cascade of
events comes from the observation that strategies that reduce ventilator-induced lung injury
appear to reduce systemic inflammation in both adults [6] and neonates [9].
Another interpretation is that systemic inflammation causes lung inflammation and
thereafter the need for prolonged ventilation. Under these circumstances, one would expect
infants requiring 14 days of ventilation to have higher early blood concentrations of pro-
inflammatory cytokines than infants who were exposed to ventilation for shorter times.
Although the concentrations of some inflammation-associated proteins increased from day 1
to day 7 to day 14, infants ventilated the longest did not tend to have appreciably higher
protein concentrations on postnatal days 1 and 7. Thus, our data support the hypothesis that
“prolonged” ventilation contributes to systemic inflammation rather than the reverse, at least
during the first 14 postnatal days. After this early time span, systemic inflammation might
very well contribute to the need for prolonged ventilation [18].
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We also explored the possibility that a specific cause of systemic inflammation, bacteremia,
contributed to an increased risk of prolonged ventilation. Support for that possibility comes
from the observation that bacteremic preterm newborns require more ventilation assistance
than their non-bacteremic peers [19]. With or without a cause and effect relationship,
bacteremia can obscure the relationship between ventilation duration and systemic
inflammation. To minimize such confounding, we carried out separate analyses in the entire
sample and in the sub-sample of newborns who did not have bacteremia documented during
the first two postnatal weeks. We found that even in this bacteremia-free group of children,
ventilation duration was strongly associated with elevated concentrations of inflammation-
associated proteins. Thus, we draw the inference that our findings are not confounded by
bacteremia.
The findings of our study might explain, in part, why prolonged ventilation appears to
increase the risks of bronchopulmonary dysplasia [20], cerebral palsy [21], and cognitive
limitations [22-24]. These findings support the hypothesis that mechanical ventilation
initiates or potentiates systemic inflammation in premature infants, which then leads to
organ damage and adverse outcomes.
4.2. potential confounders
We examined antenatal events that might increase (e.g. chorioamnionitis) or decrease (e.g.
antenatal corticosteroids) inflammatory protein concentrations during the early neonatal
period. The presence of chorioamnionitis had a negligible effect on the association between
duration of ventilation and protein concentrations. One explanation for this finding is that
the fetus might down-regulate inflammation and modulate the effects of chronic
inflammatory stimuli [25].
Fetal exposure to antenatal corticosteroids might be expected to decrease the systemic
inflammatory response in ELGANs. However, antenatal corticosteroids did not modify the
relationship between duration of ventilation and inflammation-associated proteins in our
cohort. This finding is similar to observations in the premature lamb, where antenatal
treatment with betamethasone decreases subsequent lung injury but not the systemic acute
phase response [26]. In contrast, pretreatment of adult animals with corticosteroids
attenuates both pulmonary and systemic inflammation caused by mechanical ventilation
[27].
4.3. CRP and SAA
CRP and SAA are the only proteins whose day-14 concentrations tended to be significantly
higher among those ventilated for 7-13 days, but not among those ventilated for 14 days.
Unlike the other proteins we measured, these acute phase response are synthesized mainly
by hepatocytes. It is possible that their origin outside the lung influences the timing of their
appearance in blood. It is also possible that levels are modulated by factors unrelated to
ventilation. In the absence of knowledge about these influences in ELGANs, we are unable
to provide an explanation for why CRP and SAA differ from other proteins.
4.4. RANTES and VEGF
Longer duration of ventilation was accompanied by a decreased risk of elevated
concentrations of the chemokine RANTES. This finding might appear to be inconsistent
with the expectation of increased concentrations of other chemokines following a stimulus
that promotes inflammation. However, this finding is in keeping with observations that
RANTES appears to protect against organ damage in some animal models [28, 29], and our
observation that human preterm newborns who had elevated blood concentrations of
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RANTES during the first postnatal weeks were at reduced risk of bronchopulmonary
dysplasia [1].
Our finding of an inverse relationship between ventilation duration and high concentrations
of VEGF is what would be expected if ventilation, in part via reduced VEGF concentrations,
impaired lung angiogenesis. For example, levels of VEGF are decreased in the lung
epithelial fluid from infants who develop bronchopulmonary dysplasia [30], and a paucity of
pulmonary capillaries is seen in animal models of mild bronchopulmonary dysplasia [31]. In
addition, ventilation appears to down-regulate gene expression of VEGF-B and other
traditional angiogenic factors in extremely preterm infants who die [32].
Strengths and limitations
This study has a number of strengths and limitations. Our large sample size permitted us to
adjust for potential risk modifiers and confounders with sufficient statistical power. We
measured a relatively large number of proteins. Our study was confined to infants in a
narrow gestational age range. However, it is in this population that prolonged mechanical
ventilation is most likely, and the consequences of systemic inflammation are most
profound.
Because of financial constraints, blood protein measurements were limited to infants who
had complete neurodevelopmental evaluation at 24 months. This resulted in the non-random
exclusion of one potentially important cohort, infants who did not survive to 24 months.
Among non-survivors, 119 died during the first postnatal week and an additional 165 died
prior to discharge. These infants were probably more likely than survivors to have been
ventilated and to have had systemic inflammation. Consequently, our requiring survival to
age 2 years probably resulted in an underestimate of the true relationship between
ventilation and systemic inflammation. Although potentially of less importance, infants who
survived but did not return for development testing (n=98) were also excluded. We are
uncertain of the impact of these exclusions.
We do not know how much more frequently newborns who were ventilated for 14 days had
unidentified pneumonia compared to newborns who were ventilated for shorter intervals
[33]. Because of the limitations imposed by our data collection, we also lack details about
potential important variables of ventilation (e.g. tidal volumes, oxygen concentrations, etc.),
which might influence the inflammatory process. Information regarding these variables
would have permitted a more detailed analysis of the antecedents of systemic inflammation.
We conclude that 14 days of ventilation is more likely than shorter durations of ventilation
to be accompanied by high blood concentrations of a variety of pro-inflammatory proteins
capable of damaging organs, and low concentrations of proteins that might protect from
inflammation-mediated organ injury. These associations do not appear to be influenced by
chorioamnionitis or exposure to antenatal corticosteroids. These findings have important
implications for both providers and researchers. If the systemic inflammation associated
with mechanical ventilation originates in the inflamed lung, then avoiding ventilation, or
ventilating infants in a manner that reduces lung inflammation, might minimize some of the
adverse consequences of systemic inflammation. Perhaps one of the criteria for deciding
among ventilation strategies should be their effects on blood concentrations of selected
proteins.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• In adults and term infants, ventilation can lead to systemic inflammation.
• Systemic inflammation is associated with short-term ventilation in preterm
infants.
• We examined systemic inflammation and duration of ventilation in preterm
infants.
• Inflammation was more evident in infants ventilated for 2 weeks than for < 1
week.
• Longer duration of ventilation may promote systemic inflammation in preterm
infants.
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Derivation of the study population, beginning with the original cohort of infants from then
ELGAN Study
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Blood concentrations of 9 inflammation-associated proteins on day 14 among newborns
classified by the cumulative number of days they were ventilated during the first 2 postnatal
weeks. Concentrations of proteins have been log transformed for illustrative purposes. The
median is the line close to the middle of each box, and the 25th and 75th centiles are
indicated by the top and bottom of the box. The length of the vertical lines above and below
the box indicates the limits of the range of values, exclusive of outliers, identified by black
dots.
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Table 2
Odds ratios (99% confidence intervals) of a concentration in the top quartile of each protein associated with
duration of ventilation after adjustment for gestational age, placental inflammation*, and antenatal
corticosteroids. The two data columns on the left present the results among the entire sample (N=726). The
two data columns on the right present the results among the newborns who did not have bacteremia during the
first two postnatal weeks (N=597). The referent group for each set of analyses consists of infants who were
ventilated less than 7 days. Statistically significantly elevated odds ratios are bolded, whereas as statistically
significantly reduced odds ratios are bolded and italicized.
Protein
Total sample Bacteremia-free sample
Vent 7-13 days Vent 14 days Vent 7-13 days Vent 14 days
INDICATORS OF SYSTEMIC INFLAMMATION
CRP 2.1 (1.1, 4.0) 1.5 (0.8, 2.8) 1.8 (0.9, 4.0) 1.6 (0.8, 3.1)
SAA 1.9 (1.03, 3.6) 1.6 (0.9, 2.9) 2.4 (1.1, 4.9) 1.5 (0.8, 3.0)
MPO 1.4 (0.8, 2.7) 1.7 (0.9, 3.0) 1.5 (0.7, 3.1) 1.9 (0.97, 3.5)
CYTOKINES AND RECEPTORS
IL-1β 1.6 (0.8, 3.0) 1.9 (1.03, 3.4) 1.4 (0.7, 3.0) 1.9 (1.0, 3.6)
IL-6 1.5 (0.8, 2.9) 1.8 (1.01, 3.4) 1.3 (0.6, 2.8) 2.0 (1.01, 3.8)
IL-6R 0.9 (0.5, 1.7) 1.0 (0.6, 1.9) 1.1 (0.5, 2.2) 1.1 (0.6, 2.1)
TNF-α 2.0 (1.02, 3.9) 2.7 (1.5, 5.1) 1.9 (0.9, 4.0) 2.9 (1.4, 5.6)
TNF-R1 1.5 (0.7, 2.9) 2.8 (1.5, 5.3) 1.3 (0.6, 3.0) 2.8 (1.5, 5.6)
TNF-R2 1.2 (0.6, 2.2) 1.5 (0.8, 2.8) 0.7 (0.3, 1.7) 1.4 (0.7, 2.7)
CHEMOKINES
IL-8 (CXCL8) 2.6 (1.3, 5.2) 3.5 (1.8, 6.6) 2.4 (1.1, 5.2) 3.5 (1.7, 7.0)
MCP-1 (CCL2) 2.0 (0.97, 4.0) 4.5 (2.3, 8.6) 1.9 (0.9, 4.3) 4.0 (2.0, 8.0)
MCP-4 (CCL13) 0.7 (0.4, 1.4) 0.7 (0.4, 1.3) 0.8 (0.4, 1.6) 0.8 (0.4, 1.4)
MIP-1β (CCL4) 0.9 (0.5, 1.7) 0.5 (0.3, 0.9) 0.9 (0.5, 1.8) 0.4 (0.2, 0.8)
RANTES (CCL5) 0.5 (0.3, 0.9) 0.2 (0.1, 0.4) 0.5 (0.3, 1.05) 0.2 (0.1, 0.4)
I-TAC ( CXCL11) 0.6 (0.3, 1.2) 0.5 (0.3, 0.9) 0.7 (0.4, 1.5) 0.5 (0.3, 1.0)
ADHESION MOLECULES
ICAM-1 (CD54) 3.7 (1.7, 7.8) 8.0 (3.9, 17) 3.0 (1.2, 7.6) 10 (4.5, 24)
ICAM-3 (CD50) 1.0 (0.5, 1.9) 0.9 (0.5, 1.6) 1.1 (0.6, 2.3) 1.1 (0.6, 2.0)
VCAM-1 (CD106) 1.0 (0.5, 1.8) 0.9 (0.5, 1.6) 0.8 (0.4, 1.7) 0.9 (0.5, 1.6)
E-SEL (CD62E) 1.3 (0.7, 2.5) 1.8 (0.97, 3.2) 1.3 (0.6, 2.8) 2.0 (1.04, 3.8)
MATRIX METALLOPROTEINASES
MMP-1 0.6 (0.3, 1.1) 0.3 (0.2, 0.6) 0.6 (0.3, 1.3) 0.4 (0.2, 0.7)
MMP-9 2.1 (1.1, 3.9) 1.9 (1.02, 3.5) 2.1 (0.99, 4.3) 2.1 (1.1, 4.0)
ANGIOGENIC PROTEINS
VEGF 0.9 (0.5, 1.7) 0.5 (0.3, 0.9) 1.0 (0.5, 2.0) 0.5 (0.3, 1.03)
VEGF-R1 1.4 (0.7, 2.6) 1.2 (0.7, 2.2) 1.5 (0.7, 3.0) 1.2 (0.6, 2.2)
VEGF-R2 1.4 (0.8, 2.6) 0.8 (0.5, 1.5) 1.2 (0.6, 2.5) 0.7 (0.4, 1.5)
IGFBP-1 0.8 (0.4,, 1.5) 0.9 (0.5, 1.7) 0.7 (0.3, 1.4) 0.9 (0.5, 1.8)
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*
Inflammation: grade 3 and stage 3 chorionic plate inflammation, or grade 3 external membrane inflammation, or grade 3 or higher umbilical cord
inflammation, or neutrophilic infiltration into fetal stem vessels in the chorionic plate
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